DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Oppenheimer - 3 Michael Wiederhorn - 3 Cigna - 1 Ittai Kidron - 1 Kidron - 1 Atlassian - 1 Morgan Stanley - 1 Rick Schafer - 1
Top related locs:
Bengaluru
Top related orgs:
Dow Jones - 1 Nasdaq - 1 Mastercard - 1 Dick's Sporting Goods - 1 Bloomberg - 1 Humana - 1 Bloomberg News - 1 Broadcom - 1

Search resuls for: "Michael Wiederhorn"


5 mentions found


☆ Here are Oppenheimer's best stock ideas heading into November
  + stars: | 2024-10-24 | by ( Sean Conlon | ) www.cnbc.com   time to read: +3 min
Looking ahead to November, Oppenheimer has updated its top stock ideas list, which features additions such as CarMax , Mastercard and Atlassian . He has an outperform rating on the stock, and his price target implies nearly 26% upside from Wednesday's close. Analyst Ittai Kidron has an outperform rating on the stock, and his $230 target reflects nearly 22% upside, as of Wednesday's close. That implies more than 15% upside from Wednesday's close. Evercore ISI also added Broadcom to its top chip stock picks ahead of its earnings report later in the year.
Persons: Oppenheimer, Michael Wiederhorn, Cigna, Ittai Kidron, Kidron, Atlassian, Morgan Stanley, Rick Schafer, Schafer, Hock Tan Organizations: Dow Jones, Nasdaq, Mastercard, Dick's Sporting Goods, Bloomberg, Humana, Bloomberg News, Broadcom, ISI
☆ Group of smaller stocks is primed for major gains ahead, according to Oppenheimer
  + stars: | 2024-10-08 | by ( Hakyung Kim | In Hakyungkim | ) www.cnbc.com   time to read: +3 min
In 2024, the small-cap benchmark Russell 2000 's 8% rise still lags the S & P 500's roughly 19% gain. However, Oppenheimer thinks there is further upside ahead for these names. The stock offers a 5% dividend yield and healthy — albeit "lumpy" — free cash flow growth, the analyst added. CCOI YTD mountain Cogent Communications in 2024 Health-care services stock Chemed is another one of Oppenheimer's favorites. The online sports-betting (OSB) data provider could surge more than 37%, based on the $10 price target Oppenheimer holds on shares.
Persons: Oppenheimer, Russell, Timothy Horan, " Horan, Horan, Chemed, Michael Wiederhorn, Wiederhorn, Jed Kelly, — CNBC's Michael Bloom Organizations: Federal Reserve, Genius Sports, National Football League, Football, Professional
☆ UnitedHealth offers over $3 bln for home health firm Amedisys
  + stars: | 2023-06-05 | by ( Leroy Leo | ) www.reuters.com   time to read: +2 min
June 5 (Reuters) - UnitedHealth Group (UNH.N) on Monday made a surprise $3.26 billion all-cash offer to acquire Amedisys Inc (AMED.O), pitting itself against another healthcare company set to buy the home health and hospice care firm. UnitedHealth, through its Optum unit, offered to pay $100 per share in cash, just a month after Amedisys agreed to be bought by Option Care Health Inc (OPCH.O) for $97.38 per share in an all-stock deal. If Optum's offer is accepted by Amedisys, the deal will expand UnitedHealth's presence in home healthcare that it bolstered this year through a $5.4 billion deal to buy Amedisys' rival, LHC Group. Several analysts raised concerns that a UnitedHealth deal would likely face scrutiny from the Federal Trade Commission, given UnitedHealth's home health presence. Amedisys' board has not yet determined whether Optum's offer is superior to Option Health's and is currently in exploratory discussions with the UnitedHealth unit.
Persons: Amedisys, Jefferies, Brian Tanquilut, Oppenheimer, Michael Wiederhorn, Leroy Leo, Shounak Dasgupta, Shinjini Organizations: UnitedHealth, Amedisys Inc, Care Health Inc, LHC, Federal Trade Commission, FTC, Care, Thomson Locations: Bengaluru
☆ TipRanks reveals the top 10 health care sector analysts of the past decade
  + stars: | 2023-05-21 | by ( Tipranks.Com Staff | ) www.cnbc.com   time to read: +5 min
TipRanks leveraged its Experts Center tool to recognize the ones with a high success rate. We also analyzed each stock recommendation made by health care sector analysts in the past decade. TipRanks' algorithms calculated the statistical significance of each rating, average return and the analysts' overall success rate. The buy recommendation generated a return of 397.9% from May 12, 2020 to May 12, 2021. Boris Peaker - TD CowenBoris Peaker has the 10th spot on the list, with a success rate of 47%.
☆ Humana profit beats estimates as investment income exceeds expectations
  + stars: | 2023-02-01 | by ( Khushi Mandowara Leroy Leo | Khushi Mandowara | Leroy Leo | ) www.reuters.com   time to read: +2 min
Companies Humana Inc FollowFeb 1 (Reuters) - Humana Inc (HUM.N) on Wednesday beat Wall Street estimates for quarterly profit as the health insurer's investment income jumped, even as the company reported higher-than-expected medical costs. Health insurers' costs were expected to decline on lower COVID-19-related hospitalizations, though there were concerns around a surge in flu and respiratory syncytial virus cases in the last quarter of 2022. The health insurer said it expects to add at least 625,000 members to its Medicare Advantage plan this year. Excluding one-off items, the health insurer reported a profit of $1.62 per share, higher than analysts' average estimate of $1.46 per share, according to Refinitiv data. The company's $160 million investment income was higher than Wall Street estimates of $136.7 million, Oppenheimer analyst Michael Wiederhorn said.
0 next >>
Total: 5